Study: Denying anti-depressants for teens, young adults raises risk of suicides
Government warnings a decade ago about the risks associated with children and adolescents taking anti-depressants, such as Paxil and Zoloft, appear to have backfired — causing an increase in suicide attempts and discouraging many depressed young people from seeking treatment, according to a study published on Wednesday.
Because of FDA warnings about SSRIs — selective serotonin reuptake inhibitors — anti-depressant prescriptions fell sharply for adolescents ages 10 to 17 and for young adults ages 18 to 29. At the same time, researchers found that the number of suicide attempts rose by more than 20 percent in adolescents and by more than a third in young adults.
Show commenting policy
TribLive commenting policy
- Deal to improve veterans’ health care costs $17B
- Ebola only a plane ride away from U.S.
- GAO seeks more drinking water safeguards
- Medicare finances improve as health care inflation slows, trustees say
- $17B remedy for VA pitched
- Powerful tornado surprises area near Boston
- Defense workers with security clearance owed millions in back taxes, GAO finds
- Jury picked for trial of former Virginia governor, wife
- Cellphone users can soon declare freedom from wireless carriers
- Obama mulls large-scale move on immigration
- ‘Pawn Stars’ store owner plans nearby shopping plaza